Related Experiment Video

Updated: Aug 11, 2026

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb (BCG lux/M.Tb lux)
08:10

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb (BCG lux/M.Tb lux)

Published on: September 14, 2011

Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis

Vasan K Sambandamurthy1, William R Jacobs

  • 1Department of Microbiology and Immunology, Howard Hughes Medical Institute, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

Microbes and Infection
|May 26, 2005
PubMed

Insights

Genetic tools enable the creation of Mycobacterium tuberculosis mutants to study tuberculosis pathogenesis. Some mutants show promise as safe and effective tuberculosis vaccine candidates.

Area of Science:

  • Microbiology
  • Immunology
  • Genetics

Background:

  • Mycobacterium tuberculosis (M. tuberculosis) is the causative agent of tuberculosis.
  • Understanding M. tuberculosis virulence and pathogenesis is crucial for developing effective treatments and vaccines.
  • Advances in genetic manipulation tools have facilitated the study of M. tuberculosis.

Purpose of the Study:

  • To review the role of defined M. tuberculosis mutants in understanding virulence and pathogenesis.
  • To discuss the safety and vaccine potential of selected M. tuberculosis mutants as candidate vaccines against tuberculosis.

Main Methods:

  • Construction and characterization of defined M. tuberculosis mutants using advanced genetic tools.
  • Assessment of mutant roles in M. tuberculosis virulence and pathogenesis.
  • Evaluation of the safety and immunogenicity of candidate mutant vaccines.

Main Results:

  • Defined M. tuberculosis mutants have been successfully constructed.
  • These mutants aid in elucidating the complex mechanisms of M. tuberculosis virulence and pathogenesis.
  • Preliminary data suggests that certain M. tuberculosis mutants possess favorable safety profiles and vaccine potential.

Conclusions:

  • Genetic manipulation of M. tuberculosis provides valuable insights into disease mechanisms.
  • Selected M. tuberculosis mutants represent promising candidates for novel tuberculosis vaccines.
  • Further research is warranted to fully evaluate the efficacy and safety of these mutant-based vaccines.

More Related Videos

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria06:38

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis06:26

Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

Published on: July 28, 2023

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...